Michael S Brown - Net Worth and Insider Trading
Michael S Brown Net Worth
The estimated net worth of Michael S Brown is at least $10 Million dollars as of 2024-11-13. Michael S Brown is the Director of Regeneron Pharmaceuticals Inc and owns about 12,544 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $10 Million. Details can be seen in Michael S Brown's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael S Brown has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael S Brown
Michael S Brown Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael S Brown owns 2 companies in total, including Regeneron Pharmaceuticals Inc (REGN) , and Pfizer Inc (PFE) .
Click here to see the complete history of Michael S Brown’s form 4 insider trades.
Insider Ownership Summary of Michael S Brown
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-06-14 | director |
| PFE | Pfizer Inc | 2004-04-22 | director |
Michael S Brown Latest Holdings Summary
Michael S Brown currently owns a total of 1 stock. Michael S Brown owns 12,544 shares of Regeneron Pharmaceuticals Inc (REGN) as of June 14, 2024, with a value of $10 Million.
Latest Holdings of Michael S Brown
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-06-14 | 12,544 | 821.00 | 10,298,624 |
Holding Weightings of Michael S Brown
Michael S Brown Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael S Brown has made a total of 20 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 1,535 shares on June 14, 2024, which brought Michael S Brown around $2 Million.
Insider Trading History of Michael S Brown
- 1
Michael S Brown Trading Performance
Michael S Brown Ownership Network
Ownership Network List of Michael S Brown
Ownership Network Relation of Michael S Brown
Michael S Brown Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Michael S Brown is the director of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Michael S Brown made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,814 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 26,837 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 26,837 shares. During the past 18 months, 315,919 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,919 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Michael S Brown Mailing Address
Above is the net worth, insider trading, and ownership report for Michael S Brown. Currently GuruFocus does not have mailing address information for Michael S Brown.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
